Meyer, Gabriela Pessin
da Silva, Bruna Santos
Bandeira, Cibele Edom
Tavares, Maria Eduarda Araujo
Cupertino, Renata Basso
Oliveira, Eduarda Pereira
Müller, Diana
Kappel, Djenifer B.
Teche, Stefania Pigatto
Vitola, Eduardo Schneider
Rohde, Luis Augusto
Rovaris, Diego Luiz
Grevet, Eugenio Horacio
Bau, Claiton Henrique Dotto http://orcid.org/0000-0001-5644-3845
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (476529/2012-3, 466722/2014-1, 424041/2016-2)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (finance code 001, FIPE-HCPA 160600)
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (PqG-19/2551-0003731, PqG-19/2551-001668-9)
Article History
Received: 3 September 2021
Accepted: 1 February 2022
First Online: 12 March 2022
Declarations
:
: LAR has received honoraria, has been on the speakers’ bureau/advisory board, and/or has acted as a consultant for Medicine, Novartis/Sandoz, and Shire/Takeda in the last two years; and receives authorship royalties from OxfordPress and ArtMed. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him have received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Janssen-Cilag, Novartis/Sandoz, and Shire/Takeda. EHG has served as a speakers’ bureau/advisory board for Novartis and Shire Pharmaceuticals in the past three years; and has received travel awards from Novartis and Shire for taking part in psychiatric meetings. The other authors declare no conflicts of interest.
: The authors have no relevant nonfinancial interests to disclose.
: This project was carried out following the Declaration of Helsinki. All subjects signed an informed consent form that was previously approved by the Research Ethics Committees of the participating institutions.